Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.
0 sources
Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.
Summary
Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation. is a doctoral thesis[1].
Key Facts
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation. authored Anna M. Matuszek[2].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s instance of is recorded as doctoral thesis[3].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s publisher is recorded as ResearchSpace@Auckland[4].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s country of origin is recorded as New Zealand[6].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s publication date is recorded as +2014-00-00T00:00:00Z[7].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/22141[8].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s Handle ID is recorded as 2292/22141[9].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s title is recorded as Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.[10].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s copyright holder is recorded as Anna M. Matuszek[11].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s thesis submitted to is recorded as University of Auckland[12].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s on focus list of Wikimedia project is recorded as NZThesisProject[13].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s copyright status is recorded as copyrighted[14].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s online access status is recorded as open access[15].
- Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s thesis committee member is recorded as Jóhannes Reynisson[16].
Body
Designation and Status
Defining Known Drug Space by DFT based molecular descriptors. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation.'s instance of is recorded as doctoral thesis[3].